NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Obesity and Diabetes



Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board



April 21st, 2009

Gene Network Sciences, Inc. announced that it named Dr. Eric Schadt, a leading researcher in the field of genomics-driven drug discovery, co-chair of its Scientific Advisory Board.

Dr. Schadt will be leaving his position as Executive Scientific Director of Genetics at pharmaceutical giant Merck to join forces with the departing head of Merck oncology, Dr. Stephen Friend, to create Sage, an open-access distributed data platform designed to enable collaboration by integrating the myriad of genomic data sets in the public and private domains. At Merck's Rosetta subsidiary, Dr. Schadt founded the Genetics department. His work at Merck focused on elucidating the genetic...


Source: Cancer Weekly (2009-04-21)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login